Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Catalyst Health Ventures/Activity

Catalyst Health Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Co-led Epitel's $26M Series B to expand its REMI remote wireless EEG monitoring system, alongside Genoa Ventures.

Epitel

Epitel Catalyst Health Ventures

utahbusiness.comJUL 28, 2026

JUL 28, 2026

Investment

Led a ~$7M financing round (Series B) for PanTher Therapeutics, a localized pancreatic cancer treatment company.

PanTher Therapeutics

PanTher Therapeutics Catalyst Health Ventures

caplight.comAPR 2025

APR 2025

Exit

Portfolio company Sera Prognostics priced its IPO and began trading on Nasdaq under ticker SERA.

Sera Prognostics

Sera Prognostics Catalyst Health Ventures

globenewswire.comJUL 15, 2021

JUL 15, 2021

Investment

Led PanTher Therapeutics' oversubscribed $5.4M Series A round, expanding the board ahead of its first clinical trial.

PanTher Therapeutics

PanTher Therapeutics Catalyst Health Ventures

businesswire.comJUN 17, 2021

JUN 17, 2021

Exit

Portfolio company Augmenix was acquired by Boston Scientific in a deal worth up to $600M.

Augmenix

Augmenix Catalyst Health Ventures

prnewswire.comSEP 6, 2018

SEP 6, 2018

Catalyst Health Ventures | Activity | F4